Reason for request
Inclusion
Clinical Benefit
| Substantial |
Substantial actual benefit |
Clinical Added Value
| no clinical added value |
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection. |
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
tkeMPq7XfTEmFqvb
